A Multicenter, dOuble-blind, ranDomized, placebo-controlled, parallel-group study to determine the effIcacy and safety of lucerastat oral monotherapy in adult subjects with FabrY disease.
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Idorsia Pharmaceuticals Ltd
Start Date
August 6, 2020
End Date
September 9, 2021
Administered By
Pediatrics, Medical Genetics
Awarded By
Idorsia Pharmaceuticals Ltd
Start Date
August 6, 2020
End Date
September 9, 2021